# Long Acting Paliperidone in Dually Diagnosed People With Schizophrenia: An Open-label Pilot Study

> **NCT01584466** · NA · WITHDRAWN · sponsor: **University of Maryland, Baltimore**

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Paliperidone

## Key facts

- **NCT ID:** NCT01584466
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-01
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2022-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01584466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01584466, "Long Acting Paliperidone in Dually Diagnosed People With Schizophrenia: An Open-label Pilot Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01584466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*